280 related articles for article (PubMed ID: 12874328)
1. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.
Gehring AJ; Rojas RE; Canaday DH; Lakey DL; Harding CV; Boom WH
Infect Immun; 2003 Aug; 71(8):4487-97. PubMed ID: 12874328
[TBL] [Abstract][Full Text] [Related]
2. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
Pai RK; Pennini ME; Tobian AA; Canaday DH; Boom WH; Harding CV
Infect Immun; 2004 Nov; 72(11):6603-14. PubMed ID: 15501793
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Lipoprotein Rv1016c Derived from
Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
[TBL] [Abstract][Full Text] [Related]
5. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.
Noss EH; Pai RK; Sellati TJ; Radolf JD; Belisle J; Golenbock DT; Boom WH; Harding CV
J Immunol; 2001 Jul; 167(2):910-8. PubMed ID: 11441098
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.
Fortune SM; Solache A; Jaeger A; Hill PJ; Belisle JT; Bloom BR; Rubin EJ; Ernst JD
J Immunol; 2004 May; 172(10):6272-80. PubMed ID: 15128816
[TBL] [Abstract][Full Text] [Related]
8. Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells.
Wang Y; Curry HM; Zwilling BS; Lafuse WP
J Immunol; 2005 May; 174(9):5687-94. PubMed ID: 15843570
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing.
Gehring AJ; Dobos KM; Belisle JT; Harding CV; Boom WH
J Immunol; 2004 Aug; 173(4):2660-8. PubMed ID: 15294983
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2 stimulation decreases IFN-gamma receptor expression in mouse RAW264.7 macrophages.
Curry H; Alvarez GR; Zwilling BS; Lafuse WP
J Interferon Cytokine Res; 2004 Dec; 24(12):699-710. PubMed ID: 15684737
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2.
Banaiee N; Kincaid EZ; Buchwald U; Jacobs WR; Ernst JD
J Immunol; 2006 Mar; 176(5):3019-27. PubMed ID: 16493060
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein.
Fulton SA; Reba SM; Pai RK; Pennini M; Torres M; Harding CV; Boom WH
Infect Immun; 2004 Apr; 72(4):2101-10. PubMed ID: 15039332
[TBL] [Abstract][Full Text] [Related]
13. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors.
Harding CV; Boom WH
Nat Rev Microbiol; 2010 Apr; 8(4):296-307. PubMed ID: 20234378
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis and Mycobacterium avium inhibit IFN- gamma -induced gene expression by TLR2-dependent and independent pathways.
Lafuse WP; Alvarez GR; Curry HM; Zwilling BS
J Interferon Cytokine Res; 2006 Aug; 26(8):548-61. PubMed ID: 16881865
[TBL] [Abstract][Full Text] [Related]
15. Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes.
Heise MT; Connick M; Virgin HW
J Exp Med; 1998 Apr; 187(7):1037-46. PubMed ID: 9529320
[TBL] [Abstract][Full Text] [Related]
16. Exosomes released from M. tuberculosis infected cells can suppress IFN-γ mediated activation of naïve macrophages.
Singh PP; LeMaire C; Tan JC; Zeng E; Schorey JS
PLoS One; 2011 Apr; 6(4):e18564. PubMed ID: 21533172
[TBL] [Abstract][Full Text] [Related]
17. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.
Canaday DH; Ziebold C; Noss EH; Chervenak KA; Harding CV; Boom WH
J Immunol; 1999 Jan; 162(1):372-9. PubMed ID: 9886409
[TBL] [Abstract][Full Text] [Related]
18. Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.
Barrionuevo P; Cassataro J; Delpino MV; Zwerdling A; Pasquevich KA; García Samartino C; Wallach JC; Fossati CA; Giambartolomei GH
Infect Immun; 2008 Jan; 76(1):250-62. PubMed ID: 17984211
[TBL] [Abstract][Full Text] [Related]
19. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
Mukhopadhyay S; Peiser L; Gordon S
J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling.
Pennini ME; Pai RK; Schultz DC; Boom WH; Harding CV
J Immunol; 2006 Apr; 176(7):4323-30. PubMed ID: 16547269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
